Bone Biologics Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BBLG Nasdaq 2836 www.bonebiologics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bone Biologics Corporation

BBLG Has Cash for Approval Push - Nov 17th, 2025 5:08 am
BC-Most Active Stocks - Sep 4th, 2025 8:30 am
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook - Sep 4th, 2025 5:00 am
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference - Sep 3rd, 2025 5:00 am
BBLG Has Solid Balance Sheet as Tests Progress - Aug 15th, 2025 5:25 am
Bone Biologics Announces Closing of $5.0 Million Public Offering - Jun 30th, 2025 2:10 pm
Bone Biologics Announces Pricing of $5.0 Million Public Offering - Jun 27th, 2025 7:10 am
Traders Digest Fed's Preferred Inflation Gauge as US Equity Futures Gain Pre-Bell - Jun 27th, 2025 7:02 am
BBLG Moves Toward Commercialization - Jun 27th, 2025 5:22 am
Bone Biologics Files Patent Application for Bone Regeneration Technology - Jun 27th, 2025 5:00 am
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Jun 26th, 2025 2:20 pm
BBLG Splits to Advance - Jun 11th, 2025 4:36 am
Bone Biologics Announces 1-for-6 Reverse Stock Split - Jun 6th, 2025 6:00 am
BBLG Entering Critical Stage in Good Shape - May 13th, 2025 6:15 am
BBLG Continues Crucial Testing - Feb 27th, 2025 4:17 am